COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 145 filers reported holding COHERUS BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $918,000 | -71.3% | 45,296 | -68.8% | 0.46% | -40.3% |
| Q2 2019 | $3,204,000 | +4.4% | 145,000 | -35.6% | 0.78% | -31.5% |
| Q1 2019 | $3,069,000 | +87.7% | 225,000 | +127.0% | 1.13% | +93.7% |
| Q3 2018 | $1,635,000 | +16.8% | 99,101 | -0.9% | 0.58% | +8.6% |
| Q2 2018 | $1,400,000 | – | 100,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |